Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Nitric oxide synthase inh… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility.

Artikel i vetenskaplig tidskrift
Författare Caroline Wass
Lennart Svensson
Kim Fejgin
Erik Pålsson
Trevor Archer
Jörgen Engel
Daniel Klamer
Publicerad i Pharmacology, biochemistry, and behavior
Volym 89
Nummer/häfte 3
Sidor 352-9
ISSN 0091-3057
Publiceringsår 2008
Publicerad vid Psykologiska institutionen
Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi
Sidor 352-9
Språk en
Länkar dx.doi.org/10.1016/j.pbb.2008.01.01...
Ämnesord Animals, Cognition, drug effects, Enzyme Inhibitors, pharmacology, Male, NG-Nitroarginine Methyl Ester, pharmacology, Nitric Oxide, biosynthesis, Nitric Oxide Synthase, antagonists & inhibitors, Phencyclidine, pharmacology, Rats, Rats, Sprague-Dawley, Stereotyped Behavior, drug effects, Swimming
Ämneskategorier Farmakologi och toxikologi

Sammanfattning

Schizophrenia encompasses, amongst other symptoms, a heavy load of cognitive dysfunctionality. Using the psychotomimetic agent, phencyclidine (PCP), we have previously found that PCP-induced disruptions of cognitive function in translational rodent models of schizophrenia are dependent on nitric oxide (NO) production. In the present study, male Sprague-Dawley rats were subjected to a Morris water maze task designed to assess cognitive flexibility (i.e. the ability to cope with an increasingly demanding cognitive task) by means of a "constant reversal learning paradigm". Experiments were conducted to evaluate the effects of the NO synthase inhibitor, L-NAME (10 mg/kg), on PCP-induced (2 mg/kg) impairments. Control animals significantly improved their learning over the first 3 consecutive days, whereas PCP-treated animals failed to show any significant learning. Pretreatment with L-NAME normalized the PCP-induced disruption of learning to control levels. These findings suggest that PCP-induced disruptions of cognitive flexibility (i.e. ability to modify behaviour according to an increasingly demanding cognitive task) are dependent upon NO production. These observations, together with accumulated clinical findings, suggest that the NO system is a potential treatment target for cognitive dysfunctions in schizophrenia.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?